Time-restricted Eating Acceptability, Efficacy and Safety in Obesity
1 other identifier
interventional
46
1 country
1
Brief Summary
A randomized controlled trial to determine adherence, acceptability and safety of time restricted eating (TRE) in healthy, sedentary, free-living adults with obesity between the ages of 19-65 years when following 16:8 TRE for 8 weeks. This 9-week study includes a baseline week and 8 weeks of the intervention period. Participants are randomly assigned to the TRE or the non-fasting control group. The TRE group will consume calorie containing food and drink only over an 8 hour period and rest of the 16 hour would be fasting. Adherence to TRE and calorie intake are the primary outcomes. Motivators, facilitators and barriers to TRE, hunger and cravings levels, weight bias internalization, body composition (weight, body fat%, fat mass and muscle mass) , Healthy Eating Index (HEI) to assess diet quality, skin carotenoid levels, disordered eating risk, sleep quality, and perceptions of health and well-being are secondary outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 15, 2024
CompletedFirst Posted
Study publicly available on registry
November 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedDecember 6, 2024
December 1, 2024
1.2 years
November 15, 2024
December 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Adherence
Percent of days during the 8-week trial when TRE was adhered to as recommended. This will be self-reported daily.
8 weeks
Total calorie intake
Pre and post intervention measurements of calorie intake based on three 24-hour food recall surveys using the NDSR software.
During baseline week and week 8 of the intervention
Secondary Outcomes (14)
Body weight (kg)
At baseline and at the end of 8 weeks of intervention
24-hour physical activity energy expenditure (PAEE)
During baseline week and week 8 of the intervention
Body fat percentage (%)
At baseline and at the end of 8 weeks of intervention
Fat-free mass (kg)
At baseline and at the end of 8 weeks of intervention
Fat mass (kg)
At baseline and at the end of 8 weeks of intervention
- +9 more secondary outcomes
Study Arms (2)
Time Restricted Eating Group
EXPERIMENTALThe TRE group will consume calorie-containing food and drinks only over an 8-hour window between 6 a.m. to 8 p.m. for 8 weeks. During the fasting period, they can take only calorie-free fluids.
Control
NO INTERVENTIONThey will follow their usual eating patterns and consume food over a period of 12 hours or more.
Interventions
The intervention group will eat and drink in a prescribed daily feeding window of 8-hour between 6 a.m. to 8 p.m. for 8 weeks and follow their normal exercise and resistance training routines. We will allow +/-1 hour starting and ending times for the eating window while aiming for an 8-hour eating window
Eligibility Criteria
You may qualify if:
- Age 19 to 65 years
- Owns a smartphone
- Apparently healthy
- BMI ( more than or equal to 25 kg/m2 ) and high body fat percent (BF%) (≥25% and ≥35% for males and females, respectively)
- Sedentary lifestyle (less than 150 minutes of self-reported moderate to vigorous activity per week)
- Self-reported eating interval of ≥12 h per day
You may not qualify if:
- Diagnosed diabetes mellitus (type I or II), coronary heart disease, heart failure, hypertension, hyperlipidemia, stroke, chronic lung diseases, liver or kidney disease, adrenal diseases, musculoskeletal disorders, uncontrolled thyroid disease (dose changes within the past 3 months), Crohn's disease, Ulcerative Colitis, arthritis, undergoing active cancer treatment except for non-melanoma cancer, uncontrolled psychiatric disorder (a history of hospitalization for psychiatric illness).
- Currently taking any medication that is meant for, or has a known effect on, appetite
- On anabolic steroid or hormone replacement therapy
- Participation in an exercise/nutrition/ weight-loss program within the last 6 months
- Any history of surgical intervention for weight management
- Having a ≥5% body weight change during the last 3 months
- Pregnant or less than 6 months post-partum, breastfeeding, polycystic ovarian syndrome or irregular menstruation
- missing limbs, have a pacemaker or metal implants,
- eating disorders or EAT-26 score \>20
- Alcohol or drug addiction
- Current smoker
- Works night shifts
- Unable to commit to a 9-week study
- Not willing to follow study protocol and any other contraindications.
- Currently following any of the following restrictive diets - Keto/low carbohydrate/ Vegan/ Vegetarian/ Intermittent fasting/ Paleo/ Calorie restriction/ Any other restrictive diet
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Nutrition and Hospitality Management, University of Mississippi
Oxford, Mississippi, 38677, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 15, 2024
First Posted
November 19, 2024
Study Start
June 1, 2024
Primary Completion
August 31, 2025
Study Completion
October 31, 2025
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
We will share the de-identified participant data used in the published manuscripts by depositing these data in a secure data repository. The data shared will include the sociodemographic data and the outcomes published in the manuscripts. The protocol and statistical analysis plan will be shared as supplementary material through the journal where the study if published, if allowed